Administration, Evaluation, and Planning
管理、评估和规划
基本信息
- 批准号:8728576
- 负责人:
- 金额:$ 18.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-09 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAdvocateBiostatistics CoreBudgetsCancer CenterClinicalClinical TrialsCommunicationConsultationsDataDevelopmentDisciplineDiseaseDoctor of MedicineDrug or chemical Tissue DistributionElectronicsEnsureEvaluationFundingFunding OpportunitiesGoalsInformaticsInstitutionInterdisciplinary StudyInternetLaboratoriesLeadershipMaintenanceMinorityMonitorPathologyPatientsPoliciesPreparationProgress ReportsPublicationsRegulationReportingResearchResearch PersonnelResourcesScheduleSeriesSiteSkinSkin CancerSpecialistTeleconferencesTranslationsUnited StatesUniversity of Texas M D Anderson Cancer CenterWomancareer developmentflexibilityimprovedinterdisciplinary approachinterestlecturesmeetingsmelanomapatient populationprogramsquality assuranceresearch and developmentsuccesssymposiumtissue resourcetumor
项目摘要
The Administrative Planning and Evaluation Core, Core A, is critical to the success of the SPORE. Dr. Elizabeth Grimm is the overall Core Director, and is assisted by three Co-Directors, including the founding Co-Director, Dr. Jeffrey E. Lee, who will chair the Executive Committee meetings which will be composed of all Co-PIs and one leader from each Project and Core. Two new co-directors include Patrick Hwu, M.D., as
director of the Clinical Trials Resource which for now will be incorporated as part of Core A; and Jeffrey E. Gershenwald, M.D., as overall director of patient informatics and tumor acquisition and distribution. Our Executive Committee will meet monthly to review scientific progress and fiscal status and will help surmount problems or barriers to assure that all goals are met within a realistic timeframe and within the budget constraints. This Administrative Core will schedule all meetings with investigators and assure optimum
communication with investigators at M.D. Anderson Cancer Center and elsewhere. All SPORE investigators will participate in weekly melanoma seminars and regularly report progress to the Internal Advisory Committee. An External Advisory Committee will evaluate status and progress of all SPORE research programs by annual meetings either in Houston or by web/video or teleconference. Specific responsibilities
of Core A include
* Compliance with all general, governmental and NCI regulations and requirements.
* Communication and consultation with the NCI in preparation of all required reports and
publications.
* Coordination of data control quality assurance issues
* Oversight and support for the Informatics, Tissue Resource and Pathology Core B.
* Optimization of clinical trial efforts by a Clinical Trials Management Resource in this
Core A.
* Maintenance of fiscal and budgetary functions, and managing flexibility in funding.
* Convene SPORE Administrative meetings, including the Executive Committee, the
Internal and External Advisory Committees, weekly scientific meetings, quarterly
research meetings, lectures, and symposia.
* Administration of the Developmental Research and Career Development Programs.
* Coordination and Funding of Patient Advocate activities.
* Establishment and monitoring of policies for recruitment of women and minorities of this
program.
* Coordination with other SPORE sites to promote and maintain communication and integration through sponsoring and/or attending a yearly Skin SPORE conference, and also through sharing and distribution of materials, electronic communications, and evaluation of progress reports.
行政规划和评估核心,核心A,是成功的SPORE的关键。伊丽莎白·格里姆博士是总的核心主任,并由三名联合主任协助,包括创始联合主任杰弗里·E。Lee将主持执行委员会会议,该会议将由所有Co-PI和每个项目和核心的一名领导人组成。两位新的联合董事包括帕特里克胡,医学博士,作为
临床试验资源的主任,目前将作为核心A的一部分;和杰弗里E。格申瓦尔德,医学博士,作为病人信息学和肿瘤采集和分发的总负责人。我们的执行委员会将每月举行会议,审查科学进展和财政状况,并将帮助克服问题或障碍,以确保在现实的时间框架内和预算限制内实现所有目标。该行政核心将安排与研究者的所有会议,并确保
与MD研究人员的沟通安德森癌症中心和其他地方。所有SPORE研究人员将参加每周一次的黑色素瘤研讨会,并定期向内部咨询委员会报告进展。外部咨询委员会将通过在休斯顿举行的年度会议或网络/视频或电话会议评估所有SPORE研究计划的状态和进展。具体责任
核心A包括
* 遵守所有的一般,政府和NCI法规和要求。
* 在编写所有要求的报告时与国家癌症研究所进行沟通和协商,
出版物。
* 协调数据控制质量保证问题
* 监督和支持信息学、组织资源和病理学核心B。
* 通过临床试验管理资源优化临床试验工作
核心A。
* 维持财政和预算职能,管理供资的灵活性。
* 召开SPORE行政会议,包括执行委员会、
内部和外部咨询委员会,每周科学会议,每季度
研究会议、讲座和专题讨论会。
* 发展研究和职业发展计划的管理。
* 协调和资助患者倡导活动。
* 制定和监测招募妇女和少数民族的政策,
程序.
* 通过赞助和/或参加年度皮肤孢子会议,以及通过分享和分发材料、电子通信和评估进展报告,与其他孢子站点协调,促进和保持沟通和整合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELIZABETH A GRIMM其他文献
ELIZABETH A GRIMM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELIZABETH A GRIMM', 18)}}的其他基金
UT M.D. Anderson Cancer Center SPORE in Melanoma
UT M.D. 安德森癌症中心黑色素瘤孢子
- 批准号:
7912014 - 财政年份:2009
- 资助金额:
$ 18.68万 - 项目类别:
PROGNOSTIC SIGNIFICANCE AND ANALYSIS OF iNOS IN MELANOMA
黑色素瘤中 iNOS 的预后意义和分析
- 批准号:
6993428 - 财政年份:2004
- 资助金额:
$ 18.68万 - 项目类别:
UT M.D. Anderson Cancer Center SPORE in Melanoma
UT M.D. 安德森癌症中心黑色素瘤孢子
- 批准号:
6949451 - 财政年份:2004
- 资助金额:
$ 18.68万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 18.68万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 18.68万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 18.68万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 18.68万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 18.68万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 18.68万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 18.68万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 18.68万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 18.68万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 18.68万 - 项目类别: